Clinical Trial Update: Study of Selinexor Plus DRd for Newly Diagnosed Multiple Myeloma [Phase 2]

View source ↗

Summary

This update describes a Phase 2 clinical trial evaluating selinexor in combination with DRd (daratumumab, lenalidomide, dexamethasone) for newly diagnosed multi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)
• Daratumumab (daratumumab)
• Lenalidomide (lenalidomide)
• Selinexor (selinexor)

Snippet

Sponsor: US Oncology Research | Conditions: Multiple Myeloma, Myeloma Multiple | Phase 2 | Status: ACTIVE_NOT_RECRUITING